Kenvue, the consumer health products unit spun out of J&J, announced terms for its IPO with a $3.3 billion raise.
Why it matters: If successful, Kenvue's could be the largest U.S. IPO since Rivian went public in late 2021 — and would inject much-needed optimism into the public markets.
